Carfilzomib (K) Vs Low-Dose Corticosteroids and Optional Cyclophosphamide (Cy) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma (Rrmm): Results from a Phase 3 Study (Focus) — Heinz Ludwig (2014) | RDL Network
Carfilzomib (K) Vs Low-Dose Corticosteroids and Optional Cyclophosphamide (Cy) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma (Rrmm): Results from a Phase 3 Study (Focus)
Roman Hájek, Tamás Masszi, Maria Teresa Petrucci, Antonio Palumbo, Laura Rosiñol, Arnon Nagler, Kwee Yong, Albert Oriol, Jiří Minařík, Luděk Pour, Meletios A Dimopoulos, Vladimír Maisnar, Davide Rossi, H. Kasparu, Jan Van Droogenbroeck, Dina Ben Yehuda, Izhar Hardan, Matthew Jenner, Małgorzata Całbecka, M. Dávid, Javier de la Rubia, Johannes Drach, Zoltán Gasztonyi, Slawomir Gornik, Xavier Leleu, Markus Munder, Massimo Offidani, Niklas Zojer, Kanya Rajangam, Y-L Chang, Jesús F. San Miguel, Heinz Ludwig
Shaji Kumar, Norbert Grząśko, Sossana Delimpasi, W Wiktor-Jędrzejczak, Sebastian Grosicki, Marie Christine Kyrtsonis, Andrew Spencer, Neeraj Gupta, Zhaoyang Teng, Catriona Byrne, Richard Labotka, Meletios A Dimopoulos
Shaji Kumar, Norbert Grząśko, Sosana Delimpasi, W Wiktor-Jędrzejczak, Sebastian Grosicki, Marie‐Christine Kyrtsonis, Andrew Spencer, Neeraj Gupta, Zhaoyang Teng, Catriona Byrne, Richard Labotka, Meletios A Dimopoulos
María‐Victoria Mateos, Philippe Moreau, James R. Berenson, Katja Weisel, Antonio Lazzaro, Kevin Song, Meletios A Dimopoulos, Mei Huang, Anita Zahlten‐Kumeli, A. Keith Stewart
Morten Salomo, Enrique M. Ocio, Carmen Martínez‐Chamorro, Sosana Delimpasi, Albert Oriol, Meletios A Dimopoulos, Xavier Leleu, Samuel M. Rubinstein, Nisha S. Joseph, Mercedes Gironella, Rajshekhar Chakraborty, Carlos Fernández-de Larrea, Aurora Breazna, James Drew, Anita Boyapati, Anasuya Hazra, Glenn S. Kroog, Shawn Sarkaria, Paula Rodríguez‐Otero
Discussion(0)
No comments yet. Be the first to comment.